A previous work in Huang et al. showed that in colon cancer HT-29 cells, when FGF3 was inhibited by a plasmid vector, the ratio of G0/G1 phase and G2/M phase was significantly changed, and more cells were blocked in the G2/M phase. This evidence concerns the gene FGF3 and colonic neoplasm.